242 related articles for article (PubMed ID: 23899990)
21. Cytomorphology, immunoprofile, and management of renal oncocytic neoplasms.
Zhu B; Rohan SM; Lin X
Cancer Cytopathol; 2020 Dec; 128(12):962-970. PubMed ID: 32697415
[TBL] [Abstract][Full Text] [Related]
22. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
Ishigami K; Pakalniskis MG; Leite LV; Lee DK; Holanda DG; Rajput M
Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
[TBL] [Abstract][Full Text] [Related]
23. Hybrid chromophobe renal cell neoplasm.
Mai KT; Dhamanaskar P; Belanger E; Stinson WA
Pathol Res Pract; 2005; 201(5):385-9. PubMed ID: 16047948
[TBL] [Abstract][Full Text] [Related]
24. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
[TBL] [Abstract][Full Text] [Related]
25. Reliability and Management Outcomes Following a Percutaneous Biopsy Diagnosis of Oncocytoma: A 15-year Retrospective Analysis.
Chai JL; Alencar RO; Hirsch MS; Bhagavatula S; Bay CP; Siegmund S; Chang SL; Silverman SG
Radiology; 2023 Apr; 307(2):e221156. PubMed ID: 36692400
[TBL] [Abstract][Full Text] [Related]
26. [Oncocytoma versus chromophobe renal cell carcinoma: Is there something in between?].
Lüders C; Kristiansen G
Pathologe; 2016 Mar; 37(2):153-8. PubMed ID: 26925847
[TBL] [Abstract][Full Text] [Related]
27. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
[TBL] [Abstract][Full Text] [Related]
28. Oncocytic angiomyolipoma of the kidney: a case report.
Sironi M; Spinelli M
Int J Surg Pathol; 2003 Jul; 11(3):229-34. PubMed ID: 12894359
[TBL] [Abstract][Full Text] [Related]
29. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
30. R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.
Camacho JC; Kokabi N; Xing M; Master VA; Pattaras JG; Mittal PK; Kim HS
J Vasc Interv Radiol; 2015 May; 26(5):686-93. PubMed ID: 25769213
[TBL] [Abstract][Full Text] [Related]
31. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors.
Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; Pavlinec J; O'Malley P; Su LM; Crispen PL
Abdom Radiol (NY); 2021 Jul; 46(7):3269-3279. PubMed ID: 33665734
[TBL] [Abstract][Full Text] [Related]
32. Gender differences in benign renal masses.
Mauermann J; de Martino M; Waldert M; Haitel A; Klingler HC; Remzi M; Klatte T
World J Urol; 2013 Oct; 31(5):1051-7. PubMed ID: 23417319
[TBL] [Abstract][Full Text] [Related]
33. HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.
Conner JR; Hirsch MS; Jo VY
Cancer Cytopathol; 2015 May; 123(5):298-305. PubMed ID: 25739652
[TBL] [Abstract][Full Text] [Related]
34. Bilateral benign renal oncocytomas and the role of renal biopsy: single institution review.
Leone AR; Kidd LC; Diorio GJ; Zargar-Shoshtari K; Sharma P; Sexton WJ; Spiess PE
BMC Urol; 2017 Jan; 17(1):6. PubMed ID: 28081704
[TBL] [Abstract][Full Text] [Related]
35. Renal mass biopsy using Raman spectroscopy identifies malignant and benign renal tumors: potential for pre-operative diagnosis.
Liu Y; Du Z; Zhang J; Jiang H
Oncotarget; 2017 May; 8(22):36012-36019. PubMed ID: 28415596
[TBL] [Abstract][Full Text] [Related]
36. Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients.
Giunchi F; Fiorentino M; Vagnoni V; Capizzi E; Bertolo R; Porpiglia F; Vatrano S; Tamberi S; Schiavina R; Papotti M; Bollito E
Pathology; 2016 Jan; 48(1):41-6. PubMed ID: 27020208
[TBL] [Abstract][Full Text] [Related]
37. Correlating Preoperative Imaging with Histologic Subtypes of Renal Cell Carcinoma and Common Mimickers.
Gordetsky J; Zarzour J
Curr Urol Rep; 2016 Jul; 17(7):52. PubMed ID: 27154238
[TBL] [Abstract][Full Text] [Related]
38. Oncocytoma-like angiomyolipoma. A clinicopathologic and immunohistochemical study of 2 cases.
Martignoni G; Pea M; Bonetti F; Brunelli M; Eble JN
Arch Pathol Lab Med; 2002 May; 126(5):610-2. PubMed ID: 11958671
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of benign from malignant solid renal lesions using CT-based radiomics and machine learning: comparison with radiologist interpretation.
Wentland AL; Yamashita R; Kino A; Pandit P; Shen L; Brooke Jeffrey R; Rubin D; Kamaya A
Abdom Radiol (NY); 2023 Feb; 48(2):642-648. PubMed ID: 36370180
[TBL] [Abstract][Full Text] [Related]
40. Primary collision tumors of the kidney composed of oncocytoma and papillary renal cell carcinoma: A review.
McCroskey Z; Sim SJ; Selzman AA; Ayala AG; Ro JY
Ann Diagn Pathol; 2017 Aug; 29():32-36. PubMed ID: 28807339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
